Apellis Pharmaceuticals, Inc.
2021 Q1 - 2025 Q4 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,052 | 0.0% | 81,698 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 2,582 | 0.0% | 114,088 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 2,440 | 0.0% | 140,975 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 2,672 | 0.0% | 122,175 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 3,671 | 0.0% | 115,045 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 3,253 | 0.0% | 112,795 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 3,138 | 0.0% | 81,800 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 2,974 | 0.0% | 50,600 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 1,784 | 0.0% | 29,800 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 934 | 0.0% | 24,550 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 91 | 0.0% | 1,000 | 6/30/2023 |
| 2021 Q1 | 5/14/2021 | 32 | 0.0% | 750 | 3/31/2021 |